---
title: "Century Health's $5M Seed: 97% Clinical Abstraction Accuracy Is the Headline That Matters"
description: "Century Health raised $5M seed in NYC — CHARM model hits 97% accuracy on clinical data abstraction for life sciences R&D."
date: 2026-05-19T00:00:00.000Z
tags: ["2026-vc-news", "nyc-vc-news", "startup-funding", "venture-capital", "healthtech", "biopharma", "nyc-startups"]
source: https://venturecapitaltracker.com/2026-century-health-5m-seed-clinical-ai-nyc
---

# Century Health's $5M Seed: 97% Clinical Abstraction Accuracy Is the Headline That Matters

> Century Health raised $5M seed in NYC — CHARM model hits 97% accuracy on clinical data abstraction for life sciences R&D.

Life sciences doesn't need another chatbot. **It needs clean clinical data.** Century Health raised **$5M seed** because their abstraction model reportedly hits **97% accuracy vs expert judgment**.

### What they actually do
Apply AI to **real-world clinical data** — structuring charts, notes, and specialty provider data so pharma can run **drug development, market access, and outcomes research** faster.

### Why accuracy is the whole game
Bad abstraction = bad trials = regulatory risk. Founders who lead with "AI" lose. Founders who lead with **validated accuracy on clinician-labeled gold sets** win seed rounds in 2026.

### Investor map
Origin Ventures (lead), InnovateHealth, 25madison, Next Play, 2048, Alumni — plus angels including **Zorba Lieberman (Citeline founder)** and specialty clinicians.

### Practical takeaway
NYC healthtech seed is funding **data infrastructure with clinical rigor**, not wellness wrappers. Show your eval methodology before your pitch deck animation.

### Sources
1. PR Newswire: https://www.prnewswire.com/news-releases/century-health-raises-5m-seed-round-as-ai-powered-platform-achieves-97-accuracy-in-clinical-data-abstraction-302776170.html
2. VC News Daily: https://vcnewsdaily.com/

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.